In the latest trading session, Pfizer (PFE) closed at $23.72, marking a -2.47% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.72%. Meanwhile, the Dow ...

HSBC downgraded Pfizer Inc. PFE on Monday, citing that the company’s near-term re-rating prospects have weakened despite its ...

The British company is developing two ADCs against B7-H3 and HER2 using a novel payload it is betting can overcome resistance to other ADCs.

Brandon Capital will receive more than $300 million from the sale of Myricx, which is developing cancer-killing “biological ...

Futures are trading higher as we get ready to start the first full week of trading for the third quarter, as traders and ...

A Congressional investigation is looking into whether drug trials in China that involved U.S. companies possibly took place ...

Zoetis has seen its valuation compress dramatically, now trading at just 12x trailing earnings after a 52% 12-month share ...

Pfizer Inc. (NYSE:PFE) is one of the best dividend stocks to buy, according to hedge funds. On June 24, the US Food and Drug ...

Drugmakers are working on a potential new shot to prevent the tick-borne illness. How might it fare in the era of vaccine ...

Knoa Pharma's new CEO, Michael Goettler, will lead a company that was created through Purdue Pharma's bankruptcy process.

Congressional letters sent to the CEOs of Eli Lilly, Pfizer, Merck, BMS and AbbVie this week voicing concerns about the pharmas’ clinical trials in China highlight an ongoing discrepancy in how ...

Nicola met dozens of other women with the same rare tumours and one thing in common - they all took the Depo Provera jab over ...